SLC7A11 and cancer: SLC7A11 is the gate keeper for antiporter of cystine-glutamate, also involved in cancer development (Liu et al., 2019), Newest study have indicated that SLC7A11 mediated the radiotherapy and immunotherapy of cancers via ferroptosis, which implied the role of SLC7A11 in regulating ferroptosis of cancers (Lang et al., 2019).